Tramadol (Tramadol)



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 43.2%
Pain 13.5%
Rheumatoid Arthritis 13.5%
Analgesic Therapy 8.1%
Antiviral Prophylaxis 5.4%
Back Pain 5.4%
Anxiety 2.7%
Depression 2.7%
Intentional Drug Misuse 2.7%
Osteoarthritis 2.7%
Epilepsy 12.5%
Toxicity To Various Agents 12.5%
Overdose 8.3%
Tachycardia 8.3%
Haematoma 4.2%
Hallucination 4.2%
Loss Of Consciousness 4.2%
Oedema Peripheral 4.2%
Pain 4.2%
Psychomotor Hyperactivity 4.2%
Rhinorrhoea 4.2%
Sleep Disorder 4.2%
Suicidal Ideation 4.2%
Tremor 4.2%
Urinary Tract Infection 4.2%
Ventricular Failure 4.2%
Vomiting 4.2%
Wrong Technique In Drug Usage Process 4.2%
Secondary
Product Used For Unknown Indication 72.0%
Drug Use For Unknown Indication 5.7%
Rheumatoid Arthritis 2.9%
Completed Suicide 2.3%
Pain 2.3%
Fibromyalgia 1.7%
Hiv Infection 1.7%
Ill-defined Disorder 1.7%
Neuropathy Peripheral 1.7%
Arthritis 1.1%
Prostatomegaly 1.1%
Tibia Fracture 1.1%
Anxiety 0.6%
Depression 0.6%
Essential Hypertension 0.6%
Hypertonic Bladder 0.6%
Intentional Overdose 0.6%
Migraine 0.6%
Mineral Supplementation 0.6%
Non-small Cell Lung Cancer 0.6%
Toxicity To Various Agents 41.8%
Completed Suicide 9.1%
Drug Abuse 9.1%
Overdose 5.5%
Intentional Drug Misuse 3.6%
Poisoning 3.6%
Tachycardia 3.6%
Deep Vein Thrombosis 1.8%
Drug Intolerance 1.8%
Drug Level Above Therapeutic 1.8%
Exposure Via Ingestion 1.8%
Hyponatraemia 1.8%
Intentional Overdose 1.8%
Mechanical Complication Of Implant 1.8%
Metastases To Central Nervous System 1.8%
Pain 1.8%
Palpitations 1.8%
Rash Pustular 1.8%
Serotonin Syndrome 1.8%
Suicidal Ideation 1.8%
Concomitant
Product Used For Unknown Indication 18.5%
Depression 8.7%
Multiple Sclerosis 8.7%
Plasma Cell Myeloma 8.7%
Hepatitis C 5.4%
Colorectal Cancer Metastatic 4.9%
Immunodeficiency Common Variable 4.9%
Osteoporosis 4.3%
Drug Use For Unknown Indication 3.8%
Type 2 Diabetes Mellitus 3.3%
Arthralgia 3.3%
Chronic Lymphocytic Leukaemia 3.3%
Hypertension 3.3%
Nephrogenic Anaemia 3.3%
Type 2 Diabetes Mellitus 3.3%
Actinic Keratosis 2.7%
Back Pain 2.7%
Neuralgia 2.7%
Drug Use For Unknown Indication 2.2%
Chronic Myeloid Leukaemia 2.2%
Vomiting 13.8%
Weight Increased 8.8%
Tremor 7.5%
Weight Decreased 6.3%
White Blood Cell Count Decreased 6.3%
Myocardial Infarction 5.0%
Pain In Extremity 5.0%
Psychotic Disorder 5.0%
Rash 5.0%
Renal Impairment 5.0%
Stress Fracture 5.0%
Headache 3.8%
Transaminases Increased 3.8%
Treatment Failure 3.8%
Vision Blurred 3.8%
Anaemia 2.5%
Aphasia 2.5%
Drug Ineffective 2.5%
Duodenal Ulcer Haemorrhage 2.5%
Erythema 2.5%